The ArtixASCEND Study
Recruiting · Not applicable · NCT07135895
Conditions: Acute Lower Limb Arterial Occlusion
At a glance
- Research payments reported, 2025
- $15,100
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 250
About the trial
- Sponsor
- Inari Medical
- Tested
- Artix Thrombectomy System (device)
- Dates
- Started 2026-01-07; completion 2029-10-01
- Results posted
- Not yet
This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
From ClinicalTrials.gov, last updated 2026-11-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Stryker Corporation reported $15,100 in research payments for this study in 2025 (2 payments).
Products named: Artix Ax
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- HCA Research Institute LLC $15,100
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.